| Literature DB >> 24711962 |
Daiane Francine Meinerz1, Josiane Allebrandt1, Douglas O C Mariano1, Emily P Waczuk1, Felix Antunes Soares1, Waseem Hassan1, João Batista T Rocha1.
Abstract
Organoselenium compounds have been pointed out as therapeutic agents. In contrast, the potential therapeutic aspects of tellurides have not yet been demonstrated. The present study evaluated the comparative toxicological effects of diphenyl diselenide (PhSe)2 and diphenyl ditelluride (PhTe)2 in mice after in vivo administration. Genotoxicity (as determined by comet assay) and mutagenicicity were used as end-points of toxicity. Subcutaneous administration of high doses of (PhSe)2 or (PhTe)2 (500 µmol/kg) caused distinct genotoxicity in mice. (PhSe)2 significantly decreased the DNA damage index after 48 and 96 h of its injection (p < 0.05). In contrast, (PhTe) caused a significant increase in DNA damage (p < 0.05) after 48 and 96 h of intoxication. (PhSe)2 did not cause mutagenicity but (PhTe)2 increased the micronuclei frequency, indicating its mutagenic potential. The present study demonstrated that acute in vivo exposure to ditelluride caused genotoxicity in mice, which may be associated with pro-oxidant effects of diphenyl ditelluride. In addition, the use of this compound and possibly other related tellurides must be carefully controlled.Entities:
Keywords: Genotoxicity and mutagenicity; Organoselenium; Organotellurium
Year: 2014 PMID: 24711962 PMCID: PMC3970806 DOI: 10.7717/peerj.290
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Figure 1Structure of diphenyl diselenide and diphenyl ditelluride.
Figure 2DNA damage quantification.
Classifications of DNA damage in human leukocytes. DNA damage index was calculated from cells in different damage levels, which were classified in the visual score by the measurement of DNA migration length and in the amount of DNA in the tail. The level 5 was excluded from our evaluation.
DNA damage levels in leukocytes from mice treated with diselenide or ditelluride.
| Compound | Hours of | Damage levels of DNA | DI | ||||
|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | |||
|
|
| 61.0 ± 0.5 | 19.6 ± 2.0 | 13.4 ± 1.4 | 4.5 ± 0.8 | 1.0 ± 0.5 | 63.0 ± 2.5a |
|
|
| 77.2 ± 3.6 | 11.8 ± 1.6 | 6.6 ± 1.3 | 3.8 ± 1.1 | 0.6 ± 0.2 | 40.8 ± 7.8b |
|
|
| 48.0 ± 9.7 | 32.3 ± 9.6 | 13.0 ± 3.2 | 5.0 ± 1.0 | 1.6 ± 0.6 | 80.0 ± 9.3c |
|
|
| 63.5 ± 0.5 | 20.7 ± 6.5 | 12.5 ± 5.5 | 3.7 ± 0.5 | 0.0 ± 0.0 | 58.0 ± 4.6a |
|
|
| 80.0 ± 2.0 | 10.0 ± 2.0 | 5.0 ± 3.0 | 3.0 ± 0.6 | 2.0 ± 2.0 | 40.0 ± 1.1b |
|
|
| 59.5 ± 3.5 | 19.0 ± 7.0 | 12.0 ± 3.0 | 9.2 ± 0.8 | 1.6 ± 0.5 | 76.0 ± 1.2c |
Notes.
Distribution of damage levels in mice leukocytes exposed to diphenyl diselenide and diphenyl ditelluride (500 µmol/kg, s.c.). DNA damage is presented as DNA damage index (DI). Data are expressed as means for five independent experiments. Statistical analysis by a Kruskal-Wallis Test test followed by Dun’s test.
Figure 3Micronuclei frequency after treatment with diselenide and ditelluride.
Frequency of Micronuclei (MN) cells in mice exposed to (PhTe)2 or (PhSe)2. Mice were exposed to a single dose of diselenide or ditelluride (500 µmol/kg, s.c.). Forty eight and 96 h after the injection, blood cells were examined for the presence of micronuclei. Data are expressed as mean ± SD for 5 mice per group. ∗ denoted p > 0.01 as compared to control group; # Denoted p > 0.01 as compared to diphenyl diselenide.